Parents Sought Kratom Regulation After Son Died
A South Carolina family is pushing for stricter oversight of kratom-derived products following a fatal overdose.
Updated on Sept. 23, 2026 in Substance Abuse
Following the June 26, 2026, death of 29-year-old Micah Knox, his parents are seeking to hold manufacturers of 7-OH accountable. The family is pursuing legal action to remove the kratom-derived products from retail shelves.
Why it matters
The Knox family believes that federal and state regulatory gaps surrounding 7-OH and mitragynine have created a public safety risk. They hope that stricter oversight will prevent future overdose deaths linked to these substances.
DEA toxicology testing detected mitragynine in 51 overdose cases between 2025 and April 2026. The product 7-OH remains legal in South Carolina for individuals over the age of 21.
The players
Micah Knox
He was a 29-year-old resident whose death prompted his family to advocate for stricter state kratom regulations.
Drug Enforcement Administration
This federal agency monitors substances in overdose cases and utilizes a toxicology testing program for detection.
The details
Micah Knox, who had maintained sobriety for 9.5 months, died after toxicology results identified mitragynine in his blood. His family in Lancaster, South Carolina, is now collaborating with attorneys to challenge the manufacturers of the substances sold in local shops.
Timeline
From 2025 through April 2026, the DEA identified mitragynine in 51 overdose cases.
Micah Knox died on June 26, 2026.
The next legislative session is expected to occur next year.
Health Landscape
The debate over 7-OH products mirrors broader struggles to manage emerging substances that fall outside current controlled-substance frameworks. The failure to pass a South Carolina kratom regulation bill underscores the challenge regulators face in addressing these products.
The current legality of 7-OH in South Carolina means that these products remain accessible to anyone over 21 in gas stations and smoke shops. Residents should be aware that the lack of federal regulation can result in inconsistent safety profiles for these substances.
The takeaway
Advocates argue that legislative intervention is necessary to fill the current regulatory void regarding mitragynine-based products. Families affected by these substances continue to urge for public awareness and stricter retail oversight to protect consumers.
What happens next
State lawmakers are expected to consider potential kratom regulation legislation during the next session, scheduled for next year.
Further reading
Learn more about local efforts to address Substance Abuse in our dedicated reporting section.
Source note: This article includes information reported by Kwtx.
